Peer Reviewed Cancer
FY16 Ad Hoc Programmatic Reviewers - Programmatic Review:
Lee Krug, M.D.
Bristol-Myers Squibb
John Taylor, M.D.
University of Kansas
Ping Xie, Ph.D.
Rutgers University
Last updated Thursday, May 26, 2022